CY1110860T1 - Αναστροφη μεταγραφαση τελομερασης πτηνου - Google Patents

Αναστροφη μεταγραφαση τελομερασης πτηνου

Info

Publication number
CY1110860T1
CY1110860T1 CY20101100971T CY101100971T CY1110860T1 CY 1110860 T1 CY1110860 T1 CY 1110860T1 CY 20101100971 T CY20101100971 T CY 20101100971T CY 101100971 T CY101100971 T CY 101100971T CY 1110860 T1 CY1110860 T1 CY 1110860T1
Authority
CY
Cyprus
Prior art keywords
telomerase
poultry
reverse translation
cells
nucleic acid
Prior art date
Application number
CY20101100971T
Other languages
English (en)
Inventor
Philippe Erbs
Jean-Marc Balloul
Marina Kapfer
Nathalie Silvestre
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of CY1110860T1 publication Critical patent/CY1110860T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση κυρίως αφορά νέες ανασυνδυασμένες ανάστροφες μεταγραφάσες τελομεράσης, μόρια νουκλεϊνικού οξέος που κωδικοποιούν αυτές, κύτταρα που περιλαμβάνουν το εν λόγω μόριο νουκλεϊνικού οξέος και χρήση αυτών των κυττάρων για την παρασκευή μιας ουσίας που ενδιαφέρει.
CY20101100971T 2006-01-05 2010-10-27 Αναστροφη μεταγραφαση τελομερασης πτηνου CY1110860T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06360001 2006-01-05
EP06360047 2006-10-13
EP07703676A EP1979474B1 (en) 2006-01-05 2007-01-05 Avian telomerase reverse transcriptase

Publications (1)

Publication Number Publication Date
CY1110860T1 true CY1110860T1 (el) 2015-06-10

Family

ID=38016619

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100971T CY1110860T1 (el) 2006-01-05 2010-10-27 Αναστροφη μεταγραφαση τελομερασης πτηνου

Country Status (20)

Country Link
US (1) US9024003B2 (el)
EP (1) EP1979474B1 (el)
JP (2) JP5661243B2 (el)
KR (1) KR101337377B1 (el)
CN (1) CN102268413A (el)
AT (1) ATE477321T1 (el)
AU (1) AU2007204024B2 (el)
BR (1) BRPI0706836B1 (el)
CA (1) CA2636329C (el)
CY (1) CY1110860T1 (el)
DE (1) DE602007008360D1 (el)
DK (1) DK1979474T3 (el)
HK (1) HK1122069A1 (el)
HR (1) HRP20100484T1 (el)
PL (1) PL1979474T3 (el)
PT (1) PT1979474E (el)
RS (1) RS51525B (el)
RU (1) RU2415867C2 (el)
SI (1) SI1979474T1 (el)
WO (1) WO2007077256A1 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1979474E (pt) * 2006-01-05 2010-10-22 Transgene Sa Transcriptase inversa da telomerase aviária
EP1985305A1 (en) * 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
KR101014030B1 (ko) 2008-08-29 2011-02-14 현대자동차주식회사 와이어링 취부용 플랜지 및 제조공정
RU2560976C2 (ru) 2009-05-12 2015-08-20 Трансген Са Способ продуцирования и очистки ортопоксвируса
WO2011095596A1 (en) 2010-02-04 2011-08-11 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
JP2014518080A (ja) 2011-06-27 2014-07-28 バルネバ 細胞のスクリーニング方法
WO2013045658A1 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
WO2013045668A2 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
MX2017007178A (es) 2014-12-01 2017-08-28 Transgene Sa Formulaciones liquidas estables de virus de vacuna.
BR112017011582A2 (pt) * 2014-12-04 2018-02-27 Intervet Int Bv fibroblasto de embrião de galinha imortalizado, cultura de célula, métodos para preparação de um cef importalizado, para a replicação de um vetor viral aviário e para a preparação de uma vacina, e, vacina.
EP3452081A1 (en) 2016-05-04 2019-03-13 Transgene SA Combination therapy with cpg tlr9 ligand
EP3522920A2 (en) 2016-10-10 2019-08-14 Transgene SA Immunotherapeutic product and mdsc modulator combination therapy
CA3061678A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
JP7334124B2 (ja) 2017-06-21 2023-08-28 トランジェーヌ 個別化ワクチン
US11479792B2 (en) * 2017-07-13 2022-10-25 Upside Foods, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production
WO2020049151A1 (en) 2018-09-06 2020-03-12 Bavarian Nordic A/S Storage improved poxvirus compositions
FR3089789B1 (fr) 2018-12-14 2022-05-27 Univ Claude Bernard Lyon Production de vaccins viraux sur une lignee cellulaire aviaire
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
BR112022017438A2 (pt) 2020-03-12 2022-10-18 Bavarian Nordic As Composições que melhoram a estabilidade do poxvírus
AU2021309007A1 (en) 2020-07-13 2023-02-16 Transgene Treatment of immune depression
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002300900A (ja) * 2001-04-05 2002-10-15 National Institute Of Advanced Industrial & Technology 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法
US20050084959A1 (en) 2001-10-31 2005-04-21 Hirofumi Hamada Immortalized mesenchymal cells and utilization thereof
JP3897717B2 (ja) * 2002-04-23 2007-03-28 オリンパス株式会社 細胞移植治療材料およびその製造方法
PT1979474E (pt) * 2006-01-05 2010-10-22 Transgene Sa Transcriptase inversa da telomerase aviária

Also Published As

Publication number Publication date
CA2636329A1 (en) 2007-07-12
JP5661243B2 (ja) 2015-01-28
EP1979474B1 (en) 2010-08-11
DK1979474T3 (da) 2010-09-20
RU2008125815A (ru) 2010-02-10
KR101337377B1 (ko) 2013-12-09
JP2009521945A (ja) 2009-06-11
ATE477321T1 (de) 2010-08-15
PL1979474T3 (pl) 2011-01-31
WO2007077256A1 (en) 2007-07-12
RS51525B (en) 2011-06-30
CA2636329C (en) 2016-12-13
CN102268413A (zh) 2011-12-07
BRPI0706836B1 (pt) 2021-05-25
AU2007204024A1 (en) 2007-07-12
US9024003B2 (en) 2015-05-05
RU2415867C2 (ru) 2011-04-10
DE602007008360D1 (de) 2010-09-23
US20100173378A1 (en) 2010-07-08
HK1122069A1 (en) 2009-05-08
HRP20100484T1 (hr) 2010-10-31
WO2007077256B1 (en) 2007-10-25
BRPI0706836A2 (pt) 2011-04-05
SI1979474T1 (sl) 2010-10-29
KR20080085074A (ko) 2008-09-22
EP1979474A1 (en) 2008-10-15
PT1979474E (pt) 2010-10-22
JP2013027397A (ja) 2013-02-07
AU2007204024B2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
EA201171220A1 (ru) Мутанты fgf21 и их применение
EA201270758A1 (ru) Мутанты fgf21 и их применение
EA201070764A1 (ru) Полипептиды, обладающие активностью, усиливающей лизис целлюлозы, и кодирующие их полинуклеотиды
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
EA201391632A1 (ru) Аминокислотные последовательности, направленные против il-17a, il-17f и/или il-17a/f, и содержащие их полипептиды
EA201990619A1 (ru) Fgf21 мутанты и их применение
EA200970580A1 (ru) Таннат разагилина
DE602006018969D1 (de) Herstellung und reinigung von il-29
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
MX2017009767A (es) Nuevas proteínas específicas para la angiogénesis.
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
EA200801571A1 (ru) Композиции, содержащие молекулы ctl4-ig, и способы их получения
MX2009012846A (es) Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
EA201071320A1 (ru) Активаторы глюкокиназы
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
EA201101627A1 (ru) Рекомбинантные бактерии и их применение для получения этанола
EA200701592A1 (ru) Композиты и способы их получения и использования
MY150226A (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and medicinal use
BRPI0919236A8 (pt) Terapêutica e vacinas de combinação de gas
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
ATE478858T1 (de) Cyclische sulfone, die zur verwendung als bace- inhibitoren geeignet sind
ATE536360T1 (de) Neues nukleinsäuretransfersystem